FDA Alert: FDA Safety Communication: Labeling Changes on Mortality, Kidney Injury, and Excess Bleeding with Hydroxyethyl Starch Products

FDA Alert: FDA Safety Communication: Labeling Changes on Mortality, Kidney Injury, and Excess Bleeding with Hydroxyethyl Starch Products

Comments

Popular posts from this blog

Reduced public health measures contributed to deadly COVID-19 surge in the Americas, PAHO Director says - PAHO/WHO | Pan American Health Organization